Hormone receptor and Her2/neu status pre and post neoadjuvant chemotherapy in breast cancer: Should immunohistochemical studies be repeated?

被引：0
|
作者：
Allison, KA [1 ]
Swanson, PE [1 ]
Lawton, TJ [1 ]
机构：
[1] Univ Washington, Med Ctr, Seattle, WA 98195 USA
来源：
MODERN PATHOLOGY | 2006年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
80
引用
收藏
页码：20A / 20A
页数：1
相关论文
共 50 条
  • [31] Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy
    Sanjit Kumar Agrawal
    Sanjoy Chatterjee
    Indu Arun
    Rosina Ahmed
    Indian Journal of Surgical Oncology, 2017, 8 (2) : 245 - 246
  • [32] Association of HER2/neu with complete response in breast carcinoma with neoadjuvant chemotherapy
    Peiró, G
    Adrover, E
    Aranda, FI
    Alenda, C
    Payá, A
    Seguí, J
    LABORATORY INVESTIGATION, 2006, 86 : 38A - 38A
  • [33] Association of HER2/neu with complete response in breast carcinoma with neoadjuvant chemotherapy
    Peiró, G
    Adrover, E
    Aranda, FI
    Alenda, C
    Payá, A
    Seguí, J
    MODERN PATHOLOGY, 2006, 19 : 38A - 38A
  • [34] Evaluation of changes in the Hormone receptor, Her2 status and Ki-67 proliferation following administration of neoadjuvant chemotherapy in breast cancer
    Jelicic, I.
    Kapicl, T. Ivkovic
    Lakic, T.
    Miladinovic, M.
    Lovrenski, A.
    Hardi, L. Vuckovic
    VIRCHOWS ARCHIV, 2015, 467 : S59 - S59
  • [35] Immunohistochemical Profile of Breast Cancer With Respect to Estrogen Receptor and HER2 Status
    Gloyeske, Nika C.
    Woodard, Anna H.
    Elishaev, Esther
    Yu, Jing
    Clark, Beth Z.
    Dabbs, David J.
    Bhargava, Rohit
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (03) : 202 - 208
  • [36] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    MODERN PATHOLOGY, 2018, 31 : 54 - 54
  • [37] Alteration in Steroid Hormone and HER-2/ Neu Receptor Status Following Neoadjuvant Chemotherapy in Triple Negative Breast Cancer. Is There Any Hope?
    Das, Rama
    Basu, Parna
    Ghosh, Suman
    Guha, Debasish
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (01)
  • [38] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    LABORATORY INVESTIGATION, 2018, 98 : 54 - 54
  • [39] The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients
    Bonigliere, L.
    Torrisi, R.
    Pruneri, G.
    Colleoni, M.
    Viale, G.
    LABORATORY INVESTIGATION, 2008, 88 : 24A - 24A
  • [40] The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients
    Bouiglieri, L.
    Torrisi, R.
    Pruneri, G.
    Colleoni, M.
    Viale, G.
    MODERN PATHOLOGY, 2008, 21 : 24A - 24A
12345